Los mejores médicos del tratamiento de Pólipos nasales — TOP-120 médicos

El Prof. Dr. Fehmi Döner es un especialista en Otorrinolaringología (ORL) con más de 20 años de experiencia clínica. Se graduó en la Facultad de Medicina Cerrahpaşa de la Universidad de Estambul y completó su formación en la Facultad de Medicina de la Universidad Atatürk de Erzurum.

Obtuvo los títulos de profesor asociado y profesor en la Universidad Süleyman Demirel en Isparta, reflejando su experiencia y logros académicos. Actualmente trabaja en el Hospital Medical Park Bahçelievler de Estambul. Es reconocido por sus avanzados procedimientos en ORL y su dedicación al cuidado de los pacientes.

OP.DR.Paşa Dağıstanlı

experiencia

Educación y Formación

habilidades

El Prof. Dr. Ali Vefa YÜCETÜRK nació en Aydın en 1963. Se graduó de la Escuela Primaria Hakimiyetimilliye en 1974, de la Escuela Secundaria Turca Privada de Izmir en 1980 y se graduó de la Facultad de Medicina de la Universidad Ege en 1986.

Después de completar su servicio obligatorio en el Centro de Salud del Distrito Çelikhan de Adıyaman en 1986-89, se especializó en Enfermedades de Oído, Nariz y Garganta en la Facultad de Medicina de la Universidad Técnica de Karadeniz entre 1989 y 1992 y trabajó en la misma clínica como especialista hasta 1994. KKK en 1993. Hizo su servicio militar en el Hospital Militar de Izmir.

Comenzó a trabajar como miembro del cuerpo docente de otorrinolaringología en la Facultad de Medicina de la Universidad Celal Bayar en 1994, y se convirtió en profesor asociado en 1999 y profesor en 2005.

En 1996 realizó estudios e investigaciones sobre cirugía de laringe y parótida en la Clínica Otorrinolaringológica de la Universidad de Ferrara, Italia, con el Prof. Dr. Carlo Calearo y el Prof. Dr. Antonio Pastore.

Es miembro de la Asociación Turca de Otorrinolaringología y Cirugía de Cabeza y Cuello y de la Asociación de Laringología.

Dirigió cuatro tesis sobre cáncer de laringe, pérdida auditiva del oído interno y ronquido-apnea del sueño.

Participó en más de 40 congresos, cursos y reuniones nacionales e internacionales como ponente y participante.

Tiene 18 artículos científicos publicados en revistas internacionales y 31 nacionales, 11 artículos internacionales y 35 artículos presentados en reuniones nacionales, y 5 capítulos de libros protegidos por derechos de autor. En particular, sus estudios sobre ronquidos, apnea obstructiva del sueño, enfermedades de la voz, cáncer de laringe y microcirugía del oído han sido de vanguardia.

El cirujano Ekrem Keskin nació en 1986 en Estambul. Completó su educación en la Facultad de Medicina Cerrahpaşa de la Universidad de Estambul en 2010 y obtuvo el título de médico. Durante su residencia, recibió instrucción en estética de nariz, rostro y senos bajo la supervisión de James Zins, MD y Raffi Gurunluoglu, MD, en el Departamento de Cirugía Plástica, Reconstructiva y Estética de Cleveland Clinic, Cleveland, OHIO-EE. UU. en 2016. Después de 5 años de formación en Cirugía Plástica, Reconstructiva y Estética, completó su especialización y se convirtió en Especialista en Cirugía Plástica y Estética.

Educación

2000 a 2007 Facultad de Medicina de la Universidad de İnönü
2007 a 2012 Samsun 19 de mayo Universidad Facultad de Medicina Departamento de Otorrinolaringología Cirugía de Cabeza y Cuello



Experiencia laboral
2012/2016 Especialista en Otorrinolaringología en el Hospital Estatal Regional de Batman
2014/2016 Médico Jefe del Departamento de Otorrinolaringología del Hospital Estatal Regional de Batman
2016 Profesor Asistente Doctor en la Universidad Ondokuz Mayis
Hospital Mus Sifa 2017
2018 Hospital Internacional Samsun Medicana
Hospital Samsun Liman 2019
2021 Hospital Samsun Büyük Anadolu

Karli R, Kucuk H, Aksoy A, Ayhan E, Unal R. Melanoma maligno de la cavidad nasal: Nuestra experiencia clínica. J Hard Tissue Biol 2013

Karli R, Alacam H, Unal R, Kucuk H, Aksoy A, Ayhan E. Volumen plaquetario medio: ¿Es un parámetro predictivo en el diagnóstico de la pérdida auditiva neurosensorial súbita?. Indian J Otolaryngol Head Neck Surg 2013

Elmali M, Polat AV, Kucuk H, Atmaca S, Aksoy A. Dehiscencia del canal semicircular: frecuencia y distribución en la TC del hueso temporal y su relación con los resultados clínicos. Eur J Radiol 2013

Atmaca S, Elmali M, Kucuk H. Bulbo yugular alto y dehiscente: peligro evidente durante la cirugía del oído medio. Surg Radiol Anat 2013

Karli R, Ilkaya F, Karli A, Gunbey E, Kucuk H, Guzel H, Ayhan E. Tras una miringotomía, ¿puede la aplicación tópica de mesna ser una alternativa a la aplicación de un tubo de ventilación? Eur Arch Otorhinolaryngol 2014

Kucuk H, Kurnaz SC, Kutlar G. Expectativas de tratamiento y resultados de calidad de vida en pacientes con cáncer de laringe según diferentes métodos de tratamiento. Eur Arc Otorhinolaryngol 2014

Kucuk H. Manejo de infestaciones de sanguijuelas en las vías respiratorias superiores. Revista de Otorrinolaringología, 2019.

El Dr. Enis Ekincioglu es un cirujano plástico y especialista en otorrinolaringología. Se especializa en procedimientos estéticos faciales y cirugía de cabeza y cuello. Obtuvo el segundo premio en el 40º Congreso Nacional de ORL, reconocimiento a sus habilidades clínicas e investigación.

El Dr. Ekincioglu ha publicado numerosos artículos en revistas nacionales e internacionales de prestigio, contribuyendo al avance de su especialidad. Es miembro de la Sociedad Turca de Otorrinolaringología y Cirugía de Cabeza y Cuello, la Sociedad Europea de Rinología y la Sociedad Americana de Rinología.

2022.05 – Actualidad

ESPECIALISTA EN OÍDO, NARIZ Y GARGANTA; Asyaeastetic, Estambul/Turquía

2019.09 – 2022.05

especialista en oído, nariz y garganta , özel abat tıp merkezi

Estambul/Turquía

2017.09 –2019.09

otorrinolaringólogo; Necmi Kadıoğlu devlet hastanesi, ESTAMBUL/TURQUÍA

OREJA

– Otitis serosa y tubo auditivo

– Calcificación del oído, otosclerosis y espadectomía y aplicación de pistón de teflón

– Infecciones crónicas del oído medio y diversas cirugías de timpanoplastia.

-Tímpano perforado y cirugía

-Implante coclear

NARIZ

-Cirugía de curvatura ósea o septoplastia

-CIRUGÍA DE RINOPLASTIA

- Estética de la nariz

-Sinusitis y cirugías

-Pólipos nasales y cirugía

-Concha

-Operación endoscópica de la obstrucción del conducto lagrimal

El Dr. TayfunDemirel se graduó en la Facultad de Medicina de la Universidad de Mármara en 2000. Comenzó su residencia en otorrinolaringología y cirugía de cabeza y cuello en 2001 en el departamento de cabeza y cuello de la Facultad de Medicina de Estambul y finalizó en 2005. Ha estudiado enfermedades funcionales y estéticas y cirugías de nariz desde entonces y ha realizado más de 10.000 cirugías en otorrinolaringología, principalmente septorrinoplastias y cirugías endoscópicas de los senos nasales. También es miembro del personal académico de la Universidad Sağlık ve Teknoloji de Estambul en el departamento de Otorrinolaringología de Cabeza y Cuello. Ha estado trabajando en su propia clínica en Estambul, especializado en rinoplastia primaria y de revisión, y ha realizado cirugías exitosas desde 2020.

El Dr. Ender Şahin nació en Kırşehir, Turquía, en 1981. Se embarcó en su viaje en el campo de la medicina a una edad temprana y llegó a alcanzar grandes alturas en su carrera como destacado especialista en oído, nariz y garganta.

En 2007, el Dr. Şahin se graduó con éxito en la Facultad de Medicina de la Universidad de Hacettepe, lo que marcó el comienzo de su ilustre carrera médica. Su dedicación al campo lo llevó a realizar la especialización en el Hospital de Educación e Investigación de Ankara ese mismo año. Durante su formación especializada, participó activamente en estudios de cadáveres, centrándose particularmente en las áreas de cirugía plástica facial y de orejas.

El compromiso del Dr. Şahin con el avance de su campo se refleja en su membresía en prestigiosas asociaciones médicas, incluida la Sociedad Turca de Otorrinolaringología-Cirugía de Cabeza y Cuello (Sociedad Turca KBB), la Asociación de Cirugía Plástica Facial y la Asociación Médica Turca (Türk Tabipleri Birliği).

Actualmente trabaja en su propia clínica privada, donde se especializa en una amplia gama de procedimientos médicos, que incluyen genioplastia, amigdalectomías, corrección de tabiques desviados, rinoplastia, reconstrucción del tímpano, otoplastia (sujeción de orejas salientes), cirugía de ronquidos, cirugía endoscópica de los senos nasales, cirugía endoscópica del conducto lagrimal y cirugías de extracción de nódulos y pólipos de las cuerdas vocales.

Sus áreas particulares de interés incluyen:

• Adenoides (adenoidectomía)
• Otitis media (infección del oído medio)
• Tumores nasales (extirpación y reconstrucción de tumores)

La pasión del Dr. Ender Şahin por mejorar la calidad de vida de sus pacientes y su dedicación a la promoción del conocimiento médico lo convierten en una figura respetada en el campo de la otorrinolaringología. Su compromiso con el bienestar de sus pacientes y sus contribuciones a la comunidad médica siguen dejando un impacto duradero en el mundo de la medicina.

La Dra. Nicola Vione se especializa en Otorrinolaringología y Patología de Cabeza y Cuello.

Comenzó su formación en la Universidad de Turín donde, en 1996, obtuvo la licenciatura en Medicina y Cirugía y en 1997 la habilitación para ejercer. Posteriormente, en 2001, obtuvo el diploma de especialista en Otorrinolaringología y Patología de Cabeza y Cuello.

A lo largo de sus años de carrera ha asistido a diversos hospitales de prestigio, perfeccionándose en Cirugía Funcional y Estética de la nariz, realizando miles de intervenciones y obteniendo excelentes resultados . Asiste regularmente a cursos de especialización y congresos nacionales e internacionales, aprendiendo las técnicas más vanguardistas del momento como la rinoplastia de conservación que permite realizar operaciones de rinoplastia primaria, garantizando el respeto a la anatomía de la nariz y obteniendo una nariz extremadamente natural y con un postoperatorio más corto.

Desde 2015 colabora con el Centro de Estudios “Micheli-Pellegrini”, una de las escuelas más prestigiosas de Italia en cirugía reconstructiva rinocervical-facial, como miembro del comité científico y como profesor de Cirugía Funcional y Estética de la Nariz. Actualmente trabaja en el hospital público San Luigi Gonzaga de Orbassano (Turín), como Director Médico de la Unidad Operativa de Otorrinolaringología. También trabaja en algunas clínicas privadas, como Santa Caterina da Siena GVM y la Clínica Fornaca de Sessant.

El Dr. Vione es miembro de numerosas sociedades científicas nacionales como AICEFF (Asociación Italiana de Cirugía Estética y Funcional de la Cara), AOOI (Asociación de Otorrinolaringólogos Hospitalarios Italianos), AIOCC (Asociación Italiana de Oncología de Cabeza y Cuello) y SIOeChCF (Sociedad Italiana de Otorrinolaringología y Cirugía de Cabeza y Cuello). Registrado, desde 1997, en el Orden Provincial de Cirujanos de Asti.

El Dr. Nicola Vione es un profesional establecido en el campo de la Otorrinolaringología y particularmente experto en Cirugía Funcional y Estética de la nariz.

CURRICULUM VITAE

VOLKERT B. WREESMANN MD PhD

Consultant Otolaryngologist

Oncologic Head and Neck Surgeon

Thyroid and Parathyroid Surgeon

Facial Plastic Surgeon

Principal Positions

• Centro Medico Teknon, Barcelona, Spain

Chairman, Department of Otolaryngology-Head and Neck Surgery

July 1st 2024 – present

• Juaneda, Ciutadella Menorca, Spain

Consultant Otolaryngologist-Head and Neck Surgeon

January 2025 – present

• Avantmedic, Lleida, Spain

Consultant Otolaryngologist-Head and Neck Surgeon

July 1st 2024 – present

• Clinica Omega Zeta, Andorra

Consultant Otolaryngologist-Head and Neck Surgeon

March 1st 2022 – present

• University Hospitals Dorset NHS Foundation Trust

Consultant Otolaryngologist-Head and Neck Surgeon

August 1st 2021 – October 1st 2023

• Oxford University Hospitals NHS Foundation Trust

Honorary Consultant Otolaryngologist-Head and Neck Surgeon

May 1st 2021 – April 30th 2024

• Portsmouth Hospitals University NHS Trust, Portsmouth, UK

Consultant Otolaryngologist-Head and Neck Surgeon

July 18th 2016 – April 30th 2021

• Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK

Consultant Otolaryngologist-Head and Neck Surgeon

November 7th 2015 – May 31st 2016

• Heart of England NHS Trust, Birmingham, UK

Consultant Otolaryngologist-Head and Neck Surgeon

March 1st 2015 – October 31st 2015

• University Medical Center Utrecht, Netherlands

Consultant Otolaryngologist-Head and Neck Surgeon

November 1st 2013 – June 1st 2014

Memberships

• American Head and Neck Society – Member

Netherlands Academy of Otolaryngology - Member

Professional Licences

• United Kingdom

GMC Certification

Fully Registered Medical Practitioner with Specialist Registration with a License to Practice

Registered: 02/02/2015

GMC # 7499626

• United States of America

New York State Department of Health

New York State Education Department

Registered: July 2011

License# P80949

Physician

• Netherlands

Dutch Ministry of Health (BIG Registration)

BIG Registered: 22-06-2005

BIG #19063373601

Physician

Dutch Specialist Board (RGS)

RGS registered: 01-02-2011

RGS #1911979

Otolaryngology-Head and Neck Surgeon

• Spain

Collegi de Metges de Barcelona

COMB: 63638

• Andorra

Collegi de Metges d’Andorra

RPS: 03098

COMA: 876

Education

• Memorial Sloan-Kettering Cancer Center

Surgical Fellowship, Head and Neck Surgery

New York, New York, USA

August 1st 2011 - July 31st 2013

600 bed dedicated cancer center

Performed 1200 major oncologic head and neck resections in 2 years

• United States of America ECFMG Certification

United States Medical Licensing Examination (USMLE)

Certification: June 22nd, 2010

Scores: 

   Step I: 244/99 

   Step IIa-Clinical knowledge: 227/94

   Step IIb-Clinical Skills: PASSED

   Step III: 206/85

• Netherlands Cancer Institute

Surgical Fellowship, Head and Neck Surgery

Amsterdam, The Netherlands

February 1st 2011 - July 31st 2011

Specialized Head and Neck Cancer Surgery Department

200 bed hospital

• Amsterdam University Medical Center/Netherlands Cancer Institute

Residency Training, Otolaryngology-Head and Neck Surgery

Amsterdam, the Netherlands

February 1st 2006 – January 31st 2011

• University of Amsterdam School of Medicine

Medical Doctor (MD)

Amsterdam, the Netherlands

December 2002 - January 28th 2005

• University of Amsterdam

Doctor of Philosophy (PhD), Molecular Biology

Amsterdam, the Netherlands

Thesis title: Molecular-cytogenetic characterization of head and neck cancer

December 2nd, 2004

• Erasmus University School of Medicine

Doctoral Degree in Medicine

Rotterdam, the Netherlands

September 1994 - November 17th, 1998

Research Training

• Memorial Sloan-Kettering Cancer Center

Laboratory of Epithelial Cancer Biology, Head and Neck Service, Department of Surgery, New York, New York, USA

Research Fellowship in Molecular Oncology

Supervisors: Dr. Bhuvanesh Singh MD, PhD and Dr. Jatin P. Shah, MD, FACS

March 1st 1999 - September 30st 2002

• University of California San Francisco (UCSF)

Department of Otolaryngology-Head and Neck Surgery, San Francisco, California, USA

Post-doctoral Research Fellowship in Head and Neck Oncology

Supervisors: Dr. Steven Wang MD And Prof David Eisele MD

February 2005 - January 2006

Academic Activities

University of Amsterdam

Doctorate Examination Committee member

• September 17th, 2013 - PhD Candidate: Dr. I.J. Nixon (United Kingdom)
• October 17th 2014 - PhD Candidate: Dr. J. Pramana (Netherlands)
• November 17th 2015 - PhD candidate: Dr. H. van Monsjou (Netherlands)
• December 11th 2018 - PhD Candidate: Dr. Tihana Ibrahimpasic (United States)
• January 18th, 2021 - PhD Candidate: Dr. Laura Wang (Australia)
• June 2nd, 2021 - PhD Candidate: Dr. Caroline Verhagen (Netherlands)

Conference Faculty

• Advanced Laryngopharyngeal Cancer: Functional Preservation and Rehabilitation, Portsmouth, June 25th - 26th, 2020 (postponed due to COVID) - Chairman
• Functional Preservation and Rehabilitation after Treatment for Advanced Laryngeal Cancer, Portsmouth, March 14th - 15th, 2019 - Chairman
• Portsmouth Parathyroid Conference, Portsmouth, December 14th 2018 – Chairman

Editorial Roles

• European Journal of Surgical Oncology

Associate Editor

January 1st 2023 – present

• European Journal of Surgical Oncology

Guest Editor

March issue 2018, Volume 44, Issue 3, p275-378 - Special issue on thyroid cancer management

• Journal of Oral Pathology and Medicine

Guest Editor

November issue 2021, Volume 51, Issue 10 - Special issue on vascular malformations and tumors of the head and neck

• Scientific Journal Reviewer

Oral Oncology, European Journal of Surgical Oncology, Journal of Surgical Oncology, Head and Neck, International Journal of Cancer

• Scientific Project and Grant Reviewer

Netherlands: Dutch Cancer Society

France: Institute National du Cancer

Awards

• New York Head and Neck Society

Annual Meeting, New York, NY, March 2002

Title of study presented: “MUC1 is a target if 1q amplification and pertains a grave clinical prognosis in papillary thyroid cancer”

Invited Lectures

• European Society of Surgical Oncology meeting, Krakow, 2016
• Barcelona Society of Neurosurgery, Annual Meeting, Baqueira, Spain, February, 2017
• University of Edinburgh, Department of Otolaryngology Academic Conference, March 17th 2017
• Medilex: Performance of Medical Specialists, Zeist, Netherlands, November 9th 2017
• Medilex: Performance of Medical Specialists, Driebergen, Netherlands, October 11th 2017
• Wessex Head and Neck and Thyroid Network Education Day, May 3rd, 2017
• Portsmouth Parathyroid Conference, Portsmouth, UK, December 14th 2018
• Global Post-laryngectomy Rehabilitation Academy, Portsmouth, UK, March 14th 2019
• Health Care Quality Conference, Beverwijk, Netherlands, March 25th, 2019

Published Research Reports

• The growing precision of diagnostic pathways in thyroid nodule evaluation. 

Bekker J, Wreesmann VB. 

Eur J Surg Oncol. 2025 Jan;51(1):109374.

• Special issue: Management of vascular tumors and malformations of the head and neck. 

Oomen KPQ, Brennan PA, Wreesmann VB. 

J Oral Pathol Med. 2022 Nov;51(10):829.

• Angiosarcomas of the head and neck: Impact of large data analysis on clinical management. 
•  
• Wreesmann VB, Oomen KP, Brennan PA. 

J Oral Pathol Med. 2022 Nov;51(10):904-910.

• Current classification of vascular anomalies of the head and neck. 

Oomen KPQ, Wreesmann VB. 

J Oral Pathol Med. 2022 Nov;51(10):830-836.

• A novel classification of carotid body tumors.

Wreesmann VB, Nixon IJ. 

Eur. J. Surg. Oncol. May, 2021

• Management of the contralateral central neck in differentiated thyroid cancer: A contentious issue. 

Shaha AR, Tuttle RM, Wreesmann VB. 

Eur. J. Surg. Oncol. 2021 Apr;47(4):717-719.

• Improvement of oral cancer screening quality and reach: The promise of artificial intelligence. 
•  
• Kar A, Wreesmann VB, Shwetha V, Thakur S, Rao VUS, Arakeri G, Brennan PA. 

J Oral Pathol Med. 2020 Mar 11

• The risk-benefit ratio of chemoradiation treatment in head and neck squamous cell carcinoma: value of extranodal spread and margin status. 

Ammar M, Wreesmann VB. 

Journal of ENT Masterclass, Yearbook 2018, Volume 11, Nr. 1, December 1st, 2018

• Nasal obstruction secondary to an inverted midline supernumerary tooth. 

Jones L, Hilton JM, Heyman J, Viswanathan H, Wreesmann VB, Hayes SM. 

Ann R Coll Surg Engl. 2019 Jan;101(1)

• Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects in vitro and poor outcome in patients with advanced head and neck squamous cell carcinoma. 

Verhagen CVM, Vossen DM, Borgmann K, Hageman F, Grénman R, Verwijs-Janssen M, Mout L, Kluin RJC, Nieuwland M, Severson TM, Velds A, Kerkhoven R, O'Connor MJ, van der Heijden M, van Velthuysen ML, Verheij M, Wreesmann VB, Wessels LFA, van den Brekel MWM, Vens C. 

Oncotarget. 2018 Apr 6;9(26):18198-18213.

• Complete nasal obstruction secondary to pacemaker insertion. 

Jones TL, Wreesmann VB, Nilssen E, Hilton J, Hayes SM. 

Ann R Coll Surg Engl. 2018 May;100(5)

• Optimization of the risk-benefit ratio of differentiated thyroid cancer treatment. 

Nasef HO, Nixon IJ, Wreesmann VB. Eur J Surg Oncol. 

2018 Mar;44(3):276-285. Review.

• The risk/benefit ratio of differentiated thyroid cancer treatment: Exploring treatment de-escalation. 

Wreesmann VB; on behalf of EJSO. 

Eur J Surg Oncol. 2018 Mar;44(3):275.

• Aggressive differentiated thyroid cancer. 

Janjua N, Wreesmann VB. 

Eur J Surg Oncol. 2018 Mar;44(3):367-377. Review.

• Role of extracapsular nodal spread and surgical margin status in defining high-risk head and neck squamous cell carcinoma and its treatment intensity. 

Wreesmann VB. 

International Journal of Head and Neck Surgery, April-June 2017; 8(2): 76-83.

• An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer.              

Nixon IJ, Wang LY, Migliacci JC, Eskander A, Campbell MJ, Aniss A, Morris L, Vaisman F, Corbo R, Momesso D, Vaisman M, Carvalho A, Learoyd D, Leslie WD, Nason RW, Kuk D, Wreesmann V, Morris L, Palmer FL, Ganly I, Patel SG, Singh B, Tuttle RM, Shaha AR, Gönen M, Pathak KA, Shen WT, Sywak M, Kowalski L, Freeman J, Perrier N, Shah JP. 

Thyroid. 2016 Mar;26(3):373-80.

• Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma. 
•  
• Wreesmann VB, Katabi N, Palmer FL, Montero PH, Migliacci JC, Gönen M, Carlson D, Ganly I, Shah JP, Ghossein R, Patel SG. 

Head Neck. 2016 Apr;38 Suppl 1:E1192-9.

• Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer. 

Nixon IJ, Kuk D, Wreesmann V, Morris L, Palmer FL, Ganly I, Patel SG, Singh B, Tuttle RM, Shaha AR, Gönen M, Shah JP. 

Ann Surg Oncol. 2015 Jul 28.

• Prognostic value of vascular invasion in well-differentiated papillary thyroid carcinoma.
•  
• Wreesmann VB, Nixon IJ, Rivera M, Katabi N, Palmer F, Ganly I, Shaha AR, Tuttle RM, Shah JP, Patel SG, Ghossein RA. 

Thyroid. 2015 May;25(5):503-8.

• Head and neck squamous cell carcinoma in young patients.

van Monsjou HS, Wreesmann VB, van den Brekel MW, Balm AJ. 

Oral Oncol. 2013 Dec;49(12):1097-102.

• Oral and oropharyngeal squamous cell carcinomas in young patients: The Netherlands Cancer Institute experience. 

van Monsjou HS, M Lopez-Yurda, M. Hauptmann, Balm AJ, van den Brekel MM, Wreesmann VB. 

Head Neck. 2013 Jan;35(1):94-102.

• Oropharyngeal squamous cell carcinoma: a unique disease on the rise?

van Monsjou HS, Balm AJ, van den Brekel MM, Wreesmann VB. 

Oral Oncol. 2010 Nov;46(11):780-5.

• Closure of tracheoesophageal fistula with prefabricated revascularized bilaminar radial forearm free flap. 

Wreesmann VB, Smeele LE, Hilgers FJ, Lohuis PJ. 

Head Neck. 2009 Jun;31(6):838-42.

• Clinical impact of molecular analysis on thyroid cancer management. 

Wreesmann VB, Singh B. 

Surg Oncol Clin N Am. 2008 Jan;17(1):1-35.

Genetic abnormalities associated with chemoradiation resistance of head and neck squamous cell carcinoma. 

van den Broek GB, Wreesmann VB, van den Brekel MW, Rasch CR, Balm AJ, Rao PH. 

Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4386-91.

• Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer. 

Wang SJ, Wreesmann VB, Bourguignon LY. 

Head Neck. 2007 Jun;29(6):550-8.

• Downregulation of Fanconi anemia genes in sporadic head and neck squamous cell carcinoma. 
•  
• Wreesmann VB, Estilo C, Eisele DW, Singh B, Wang SJ. 

ORL J Otorhinolaryngol Relat Spec. 2007;69(4):218-25. Epub 2007 Apr 4.

• Patterns of expression of cell cycle/apoptosis genes along the spectrum of thyroid carcinoma progression. 
•  
• Saltman B, Singh B, Hedvat CV, Wreesmann VB, Ghossein R. 
•  
• Surgery. 2006 Dec;140(6):899-905; discussion 905-6.

• Repetitive endoscopic sinus surgery failure: a role for radical surgery? 

Videler WJ, Wreesmann VB, van der Meulen FW, Knegt PP, Fokkens WJ. 

Otolaryngol Head Neck Surg. 2006 Apr;134(4):586-91.

• MUC1 plays a role in tumor maintenance in aggressive thyroid carcinomas. 
•  
• Patel KN, Maghami E, Wreesmann VB, Shaha AR, Shah JP, Ghossein R, Singh B. 
•  
• Surgery. 2005 Dec;138(6):994-1001; discussion 1001-2.

• Chromosomal aberrations in squamous cell carcinomas of the upper aerodigestive tract: biologic insights and clinical opportunities. 

Wreesmann VB, Singh B. 

J Oral Pathol Med. 2005 Sep;34(8):449-59. Review.

• Molecular profiling of tumor progression in head and neck cancer.
•  
• Belbin TJ, Singh B, Smith RV, Socci ND, Wreesmann VB, Sanchez-Carbayo M, Masterson J, Patel S, Cordon-Cardo C, Prystowsky MB, Childs G. 
•  
• Arch Otolaryngol Head Neck Surg. 2005 Jan;131(1):10-8.

• Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck. 

Wreesmann VB, Shi W, Thaler HT, Poluri A, Kraus DH, Pfister D, Shaha AR, Shah JP, Rao PH, Singh B. 

J Clin Oncol. 2004 Oct 1;22(19):3965-72.

• Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity. 

Wreesmann VB, Ghossein RA, Hezel M, Banerjee D, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B. 

Genes Chromosomes Cancer. 2004 Aug;40(4):355-64.

• Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker. 

Wreesmann VB, Sieczka EM, Socci ND, Hezel M, Belbin TJ, Childs G, Patel SG, Patel KN, Tallini G, Prystowsky M, Shaha AR, Kraus D, Shah JP, Rao PH, Ghossein R, Singh B. 

Cancer Res. 2004 Jun 1;64(11):3780-9.

• Genetic abnormalities associated with nodal metastasis in head and neck cancer. 

Wreesmann VB, Wang D, Goberdhan A, Prasad M, Ngai I, Schnaser EA, Sacks PG, Singh B. 

Head Neck. 2004 Jan;26(1):10-5.

• Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. 
•  
• Kutler DI, Wreesmann VB, Goberdhan A, Ben-Porat L, Satagopan J, Ngai I, Huvos AG, Giampietro P, Levran O, Pujara K, Diotti R, Carlson D, Huryn LA, Auerbach AD, Singh B. 
•  
• J Natl Cancer Inst. 2003 Nov 19;95(22):1718-21.

• Chromosomal aberrations in patients with head and neck squamous cell carcinoma do not vary based on severity of tobacco/alcohol exposure. 

Singh B, Wreesmann VB, Pfister D, Poluri A, Shaha AR, Kraus D, Shah JP, Rao PH. 

BMC Genet. 2002 Nov 14;3:22. Epub 2002 Nov 14.

• Genome-wide appraisal of thyroid cancer progression. 
•  
• Wreesmann VB, Ghossein RA, Patel SG, Harris CP, Schnaser EA, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B. 
•  
• Am J Pathol. 2002 Nov;161(5):1549-56.

• Refractory chronic sinusitis: evaluation of symptom improvement after Denker’s procedure. 
•  
• Wreesmann VB, Fokkens WJ, Knegt PP. 
•  
• Otolaryngol Head Neck Surg. 2001 Nov;125(5):495-500.

• Inflammatory pseudotumour (inflammatory myofibroblastic tumour) of the pancreas: a report of six cases associated with obliterative phlebitis. 
•  
• Wreesmann V, van Eijck CH, Naus DC, van Velthuysen ML, Jeekel J, Mooi WJ. 
•  
• Histopathology. 2001 Feb;38(2):105-10.

• Screening for genetic aberrations in papillary thyroid cancer by using comparative genomic hybridization. 
•  
• Singh B, Lim D, Cigudosa JC, Ghossein R, Shaha AR, Poluri A, Wreesmann VB, Tuttle M, Shah JP, Rao PH. 
•  
• Surgery. 2000 Dec;128(6):888-93;discussion 893-4.

Abstracts (Presentations at scientific meetings):

• Genome-wide screening for genetic prognostic factors in papillary thyroid carcinoma. 
•  
• Wreesmann VB, Ghossein RA, Poluri A, Shaha AR, Tuttle RM, Shah JP Rao PH, Singh B. 

Fifth International Conference on Head and Neck Cancer San Francisco, CA, July 2000.

• Hierarchical Clustering (HC): a Novel Approach to Evaluating the Prognostic Value of Laboratory Parameters in Patients (Pts) Undergoing Chemoradiation Treatment (CRT) for Advanced Laryngopharyngeal Carcinoma (LPC). 

Singh B, Pfister D, Wreesmann VB, Li R, Gogineni S, Bosl G, Hoffman RH, Shah JP, Rao PH. 

37th Annual Meeting of the American Society of Clinical Oncology; New Orleans LA, May 2001.

• Gain of 1q is unique to the tall cell variant of papillary thyroid cancer. 

Wreesmann VB, Ghossein RA, Tuttle RM, Shaha AR, Robbins R, Shah JP, Rao PH, Singh B. 

73rd annual meeting of the American Thyroid Association, Washington D.C. November 2001.

• MUC1 is a target of 1q amplification and pertains a grave clinical prognosis in papillary thyroid cancer. 

Wreesmann VB, Sieczka E, Socci ND, Hezel M, Belbin TJ, Childs G, Patel SG, Shah JP, Rao PH, Ghossein RG, Singh B. 

Annual Meeting of the New York Head and Neck Society, New York, NY, March 2002.

• Genome wide screening identified gains and losses as independent prognostic variables in patients with head and neck squamous cell carcinoma (HNSCC). 

Singh B, Wreesmann VB, Thaler HT, Shi W, Shah JP, Shaha AR, Kraus DH, Boyle JO, Pfister D, Rao PH. 

38th Annual Meeting of the American Society of Clinical Oncology; Orlando, Fl May 2002.

• p53 inactivation by human papillomavirus (HPV) in Fanconi anemia associated squamous cell carcinoma. 

Kutler DI, Goberdhan A, Wreesmann VB, Giampietro PF, Auerbach AD, Singh B. 

The Sixth Research Workshop on the Biology, Prevention, and Treatment of Head and Neck Cancer; Washington D.C.; October 2002.

• Identification of novel prognostic factors in head and neck squamous cell carcinoma. 
•  
• Wreesmann VB, Shi W, Thaler HT, Shah JP, Shaha AR, Kraus DH, Boyle JO, Pfister D, Rao PH, Singh B. 

7th symposion on Research in Head and Neck Cancer; Dusseldorf, Germany, September 4-6 2003.

• Molecular profiling of aggressive papillary thyroid cancer: prognostic significance of MUC1 alterations. 

Wreesmann VB, Sieczka E, Socci ND, Hezel M, Belbin TJ, Childs G, Patel SG, Patel KN, Tallini G, Prystowsky M, Shaha AR, Kraus D, Shah JP, Rao PH, Ghossein RA, Singh B. 

7th symposion on Research in Head and Neck Cancer; Dusseldorf, Germany, September 4-6 2003.

• Chromosomal aberrations in Fanconi anemia-associated squamous cell carcinomas differ from sporadic squamous cell carcinomas from the general population. 

Kutler DI, Rao PH, Wreesmann VB, Goberdhan A, Ngai I, Huvos AG, Giampietro PF, Levran O, Pujara K, Diotti R, Auerbach AD, Singh B. 

15th annual Fanconi Anemia Research Fund scientific symposium, Houston TX, Oct 2003.

• Molecular classification of Fanconi anemia(FA)-associated head and neck squamous cell carcinoma (HNSCC) using oligonucleotide microarrays. 

Kutler DI, Ganly I, Wreesmann VB, Goberdhan A, Ngai I, Huvos AG, Giampietro PF, Levran O, Pujara K, Diotti R, Auerbach AD, Singh B. 

15th annual Fanconi Anemia Research Fund scientific symposium, Houston TX, Oct 2003.

•  
• Genotyping follicular cell-derived thyroid neoplasia: a CGH study of 150 cases.

Wreesmann VB, Ghossein RA, Socci N, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B. 

Sixth International Conference on Head and Neck Cancer, Washington DC, August 2004.

• Downregulation of Fanconi anemia genes in sporadic squamous cell carcinomas of the head and neck. 

Wreesmann VB, Estilo C, Eisele DW, Singh B, Wang SJ. 

208th meeting of the Netherlands Society of Otolaryngology-Head and Neck Surgery, Utrecht, April 7th 2006.

• Extracapsular nodal spread does not predict outcome in clinically node negative oral cavity squamous cell carcinoma. 

Wreesmann VB, Ghossein RA, Carlson D, Ganly I, Palmer F, Montero P, Shah JP, Patel SG. 

AHNS 2013 Annual Meeting, April 10 & 11, 2013, Orlando Florida.

• Minor (<2mm) extracapsular spread is not an adverse predictor of outcome in metastatic squamous cell carcinoma of the oral cavity. 

Wreesmann VB, Ghossein RA, Carlson D, Ganly I, Palmer F, Montero P, Shah JP, Patel SG. Presented at the AHNS 2014 Annual Meeting, July 2014, New York, New York.

Books, Chapters:

• Molecular Biology as applied to Head and Neck Oncology

Wreesmann VB, Singh B.

Stell and Maran's Textbook of Head and Neck Surgery and Oncology

Fifth Edition

Chapter, edited by John Watkinson and Ralph Gilbert

• Molecular-Cytogenetic Characterization of Head and Neck Cancer: Identification of molecular prognostic factors and targets of therapy

Wreesmann VB, Singh B.

Book, Amsterdam 2004

Reviewed in: Head and Neck: Volume 29, Issue 1, pages 82–83, January 2007

• Open Conservation Surgery for Laryngeal Cancer

Wreesmann VB, Ganly I

Scott-Brown's Otorhinolaryngology and Head and Neck Surgery, Eighth Edition

Chapter 27

CRC Press, Taylor-Francis Group, June 12th, 2018

• Molecular Oncology

Wreesmann V.B.

Self-Assessment in Head and Neck Surgery and Oncology, First Edition

Chapter 21

Elsevier 2014

Research grants:

Netherlands Cancer Institute “Startgeld” Grant 2008

Project: Fanconi anemia in head and neck cancer

Principal investigators: Wreesmann VB, van den Brekel MW, Balm AJM, Vens C.

Amount granted: 300.000 euro

Dr. Anıl Hişmi graduated from Ankara University Faculty of Medicine in 2002 and began his residency in Otorhinolaryngology and Head and Neck Surgery in 2003 at Ankara Numune Training and Research Hospital. He completed his specialization in 2009 and started working as an ENT specialist at Mardin State Hospital that same year.

Between 2010 and 2018, Dr. Hişmi held various positions in hospitals across Turkey, focusing on advanced ENT procedures including nasal surgery, sinus treatments and otoplasty. In 2018, he moved to the United States where he worked as a research fellow in the Department of Facial Plastic and Reconstructive Surgery in Boston, Massachusetts. This international research experience further refined his expertise in facial anatomy and functional-aesthetic surgery techniques.

From 2019 to 2022, he served as a specialist at the Ümraniye Training and Research Hospital’s ENT department, providing both surgical care and mentorship to junior colleagues. During the 2022–2024 academic years, he taught theoretical and practical ENT training at Bahçeşehir University (BAU) Faculty of Medicine, contributing to the next generation of medical professionals.

Dr. Hişmi has authored over 30 scientific publications in national and international medical journals and has been an active speaker at numerous global conferences, including the Annual Meeting of the European Academy of Facial Plastic Surgery.

With more than 20 years of surgical experience, Dr. Hişmi is known for his advanced skill in rhinoplasty, nasal airway surgery, and otoplasty. He speaks both Turkish and English fluently and combines academic precision with a highly personalized approach to patient care.

Dr. Kadri İla graduated from Istanbul University Cerrahpaşa Faculty of Medicine in 2006. He went on to complete his specialty training in Otorhinolaryngology (ENT) at Kocaeli University Faculty of Medicine Hospital, where he laid the foundation for his career in functional and aesthetic nasal surgery.

In 2020, he was awarded the academic title of Associate Professor, in recognition of his contributions to clinical practice, academic research and medical education.

His clinical focus lies in rhinoplasty and nasal airway surgery. He treats nasal septum deviation (curvature), turbinate hypertrophy (concha issues), and chronic sinusitis with an integrative approach that combines both aesthetic precision and functional correction. He is also experienced in otoplasty (ear reshaping surgery).

Dr. İla has enriched his medical perspective with international clinical experience. He worked as an observer at the Antoni van Leeuwenhoek Cancer Institute in the Netherlands, as well as in the United States. He also served as a research assistant at the University of Miami — a globally respected center for medical training and patient care.

With around 30 published scientific articles and nearly 40 presentations delivered at national and international medical congresses, he maintains a strong academic presence in his field.

Since August 2022, he has been a member of the surgical team at Vanity Cosmetic Surgery Hospital. In 2023, he was appointed Medical Director of the Private Çengelköy branch of Vanity Clinic, where he oversees surgical standards, patient care, and operational excellence.

He is a certified member of the European Board of Otolaryngology and the Turkish Society of Otorhinolaryngology. He is fluent in both Turkish and English.